Alliances

May 20th, 2022

Northpond Labs funds second Wyss Institute research project

Through the Laboratory for Bioengineering Research and Innovation, Northpond will sponsor SomaCode to support commercialization

Oliver Dodd (left) and Soufiane Aboulhouda (right) are developing SomaCode in the Harvard lab of Prof. George Church.

October 15th, 2021

Harvard University and Resilience announce five-year R&D alliance to incubate new technologies, launch companies to advance the manufacture of complex medicines

First anticipated spinout from the alliance, Circle Therapeutics, to develop novel muscle stem cell therapies for a variety of skeletal muscle disorders

Stock image of vials. Copyright Shutterstock.

February 25th, 2021

Harvard University and Kyowa Kirin enter strategic research alliance

Multiyear collaboration to advance innovation in therapeutics and biomedical technology platforms

Stock image of a therapeutic drug. Image credit: Shutterstock.

November 18th, 2020

Harvard's Wyss Institute creates research and innovation alliance with Northpond Labs

Northpond commits $12 million to create a Laboratory for Bioengineering Research and Innovation at the Wyss Institute for solutions-oriented research and development

August 25th, 2020

Harvard University, AbbVie form research alliance to address emergent viral diseases

Commitment of $30M from AbbVie supports research collaboration with Harvard Medical School to advance development of therapeutics